MCAM and neoplasm: To test whether CD146+ macrophages enhanced the antitumor efficiency of anti–PD-1 antibodies, we treated MC38 tumor-bearing M-WT and M-KO mice with anti-PD-1 and/or anti-CD146 antibodies.